Get an alert when BEONE MEDICINES UNITED KINGDOM, LTD. files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-09-01 (in 4mo)

Last made up 2025-08-18

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£53K

0% vs 2023

Employees

0

Average over period

Profit before tax

Period ending 2024-12-31

Accounts

3-year trend · latest reflected 2024-12-31

Metric Trend 2020-12-312023-12-312024-12-31
Turnover
Operating profit
Profit before tax
Net profit £0£0
Cash
Total assets less current liabilities £100£52,729£52,729
Net assets £52,729£52,729
Equity £100£52,729£52,729
Average employees 000
Wages
Directors' remuneration £0£0

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2020-12-312023-12-312024-12-31
Current ratio -0.00x-0.00x

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. BEONE MEDICINES UNITED KINGDOM, LTD. 2025-05-13 → present
  2. BEIGENE UNITED KINGDOM, LTD. 2019-08-19 → 2025-05-13

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Ernst & Young LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors have assessed the financial position and likely future cash flows of the Company at the date of approving these financial statements. The directors noted that the Company has net assets of £52,729. The Company's result is nil. As such, the ultimate parent BeOne Medicines Ltd, has confirmed through a letter of support that it will ensure that sufficient funds are available so that the Company can continue to meet its obligations until 31 December 2026.”

Group structure

  1. BEONE MEDICINES UNITED KINGDOM, LTD. · parent
    1. Beigene (Canada) ULC 100% · Canada
    2. Beigene NZ Unlimited 100% · New Zealand
    3. BeiGene (Thailand) Ltd. 0.0001% · Thailand
    4. BeiGene Argentina S.R.L. 4.72% · Argentina
    5. Beigene Mexico 5% · Mexico

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 3 resigned

Name Role Appointed Born Nationality
HARRIS, James Edwards Director 2024-08-01 Oct 1979 British
MULROONEY, Robert Dominic Director 2023-08-09 Apr 1961 Irish
Show 3 resigned officers
Name Role Appointed Resigned
DUSORUTH, Devun Director 2023-08-09 2025-02-21
MALLER, Daniel Robert Director 2019-08-19 2023-08-09
SAMUELS, Scott Alan Director 2019-08-19 2022-06-30

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Beone Medicines Uk, Ltd. Corporate entity Significant influence 2019-08-19 Active

Filing timeline

Last 20 of 30 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2025-05-13 CERTNM Certificate change of name company PDF
Date Type Category Description
2025-10-27 AA accounts Accounts with accounts type full
2025-08-26 CS01 confirmation-statement Confirmation statement with updates PDF
2025-05-13 CERTNM change-of-name Certificate change of name company PDF
2025-05-12 PSC05 persons-with-significant-control Change to a person with significant control PDF
2025-03-04 TM01 officers Termination director company with name termination date PDF
2024-10-12 AA accounts Accounts with accounts type full
2024-08-29 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-08-01 AP01 officers Appoint person director company with name date PDF
2024-01-02 AA accounts Accounts with accounts type small
2023-10-11 CH01 officers Change person director company with change date PDF
2023-10-11 AD01 address Change registered office address company with date old address new address PDF
2023-10-11 PSC05 persons-with-significant-control Change to a person with significant control PDF
2023-08-27 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-08-27 AP01 officers Appoint person director company with name date PDF
2023-08-27 TM01 officers Termination director company with name termination date PDF
2023-08-27 AP01 officers Appoint person director company with name date PDF
2022-09-28 AAMD accounts Accounts amended with accounts type dormant
2022-08-31 CS01 confirmation-statement Confirmation statement with updates PDF
2022-08-19 AA accounts Accounts with accounts type dormant
2022-07-10 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page